Provided by Tiger Trade Technology Pte. Ltd.

DexCom

73.78
+0.35000.48%
Post-market: 73.780.00000.00%19:04 EST
Volume:3.70M
Turnover:271.10M
Market Cap:28.40B
PE:35.31
High:73.91
Open:72.37
Low:71.57
Close:73.43
52wk High:89.98
52wk Low:54.11
Shares:384.86M
Float Shares:382.00M
Volume Ratio:0.90
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.09
EPS(LYR):2.09
ROE:34.50%
ROA:8.89%
PB:10.34
PE(LYR):35.31

Loading ...

DexCom Inc. Stock Advances 5.3%, Outperforms Peers

Dow Jones
·
Jan 13

DexCom Cut to Underweight From Equal-Weight by Barclays

Dow Jones
·
Jan 13

Why This Medical Device Company Is the Top Stock in the S&P 500 Today -- Barrons.com

Dow Jones
·
Jan 13

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2026-01-12

Reuters
·
Jan 13

Barclays downgrades DexCom to Underweight on rising competition

TIPRANKS
·
Jan 12

DexCom reports preliminary Q4 revenue $1.26B, consensus $1.24B

TIPRANKS
·
Jan 12

DexCom sees FY26 revenue $5.16B-$5.25B, consensus $5.23B

TIPRANKS
·
Jan 12

Glucose monitor maker Dexcom's prelim Q4 revenue beats expectations on G7 15 Day launch

Reuters
·
Jan 12

GUIDANCE: (DXCM) DexCom Expects 2026 Total Revenue Range $5.16B - $5.25B, vs. FactSet Est of $5.23B

MT Newswires Live
·
Jan 12

DexCom Projects 2026 Revenue Up to $5.25 Billion with Higher Margins

Reuters
·
Jan 12

Dexcom Inc - Anticipates 2026 Revenue at $5.16-$5.25 Bln, up 11-13%

THOMSON REUTERS
·
Jan 12

Press Release: Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Dow Jones
·
Jan 12

Assessing DexCom (DXCM) Valuation As Analyst Actions And Conference Spotlight Shape Sentiment

Simply Wall St.
·
Jan 12

DexCom Is Maintained at Outperform by Bernstein

Dow Jones
·
Jan 10

Bernstein Adjusts Price Target on DexCom to $86 From $84, Maintains Outperform Rating

MT Newswires Live
·
Jan 09

RBC Capital Reaffirms Their Buy Rating on Dexcom (DXCM)

TIPRANKS
·
Jan 09

DexCom Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jan 09

BRIEF-Dexcom Enters Next Era Of Continued Innovation With Jake Leach As Chief Executive Officer

Reuters
·
Jan 07

DexCom Names Jake Leach as President and CEO

Reuters
·
Jan 07

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

THOMSON REUTERS
·
Jan 07